Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older-Reference-Cited by-同舟云学术

Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older

Published:2016-03-28 Issue:5 Volume:91 Page:E284-E292
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Konuma Takaaki¹,Tsukada Nobuhiro²,Kanda Junya³,Uchida Naoyuki⁴,Ohno Yuju⁵,Miyakoshi Shigesaburo⁶,Kanamori Heiwa⁷,Hidaka Michihiro⁸,Sakura Toru⁹,Onizuka Makoto¹⁰,Kobayashi Naoki¹¹,Sawa Masashi¹²,Eto Tetsuya¹³,Matsuhashi Yoshiko¹⁴,Kato Koji¹⁵,Ichinohe Tatsuo¹⁶,Atsuta Yoshiko¹⁷¹⁸,Miyamura Koichi¹⁹,

Affiliation:

1. Department of Hematology/Oncology; the Institute of Medical Science, the University of Tokyo; Tokyo Japan

2. Division of Hematology; Japanese Red Cross Medical Center; Tokyo Japan

3. Division of Hematology; Jichi Medical University, Saitama Medical Center; Saitama Japan

4. Department of Hematology; Toranomon Hospital; Tokyo Japan

5. Department of Internal Medicine; Kitakyushu Municipal Medical Center; Kitakyushu Japan

6. Department of Hematology; Tokyo Metropolitan Geriatric Hospital; Tokyo

7. Department of Hematology; Kanagawa Cancer Center; Yokohama Japan

8. Department of Hematology; National Hospital Organization Kumamoto Medical Center; Kumamoto Japan

9. Saiseikai Maebashi Hospital; Leukemia Research Center; Gunma Japan

10. Department of Hematology and Oncology; Tokai University School of Medicine; Isehara Japan

11. Department of Hematology; Sapporo Hokuyu Hospital; Sapporo Japan

12. Department of Hematology and Oncology; Anjo Kosei Hospital; Anjo Japan

13. Department of Hematology; Hamanomachi Hospital; Fukuoka Japan

14. Division of Hematology; Kawasaki Medical School; Kurashiki Japan

15. Department of Hematology and Oncology; Children's Medical Center, Japanese Red Cross Nagoya First Hospital; Nagoya Japan

16. Department of Hematology and Oncology; Research Institute for Radiation Biology and Medicine, Hiroshima University; Hiroshima Japan

17. Department of Healthcare Administration; Nagoya University Graduate School of Medicine; Nagoya Japan

18. Japanese Data Center for Hematopoietic Cell Transplantation; Nagoya Japan

19. Department of Hematology; Japanese Red Cross Nagoya First Hospital; Nagoya Japan

Publisher

Wiley

Subject

Hematology

Reference58 articles.

1. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: A prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy;Yakoub-Agha;J Clin Oncol,2006

3. Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission;Walter;Leukemia,2010

4. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis;Gupta;Blood,2010

5. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia;Saber;Blood,2012

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period;Cytotherapy;2024-08

2. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status;Transplantation and Cellular Therapy;2024-02

3. Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens;Transplantation and Cellular Therapy;2023-12

4. Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia;Frontiers in Pediatrics;2023-09-13

5. Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?;Bone Marrow Transplantation;2023-05-08